Diferencia entre revisiones de «Pyrantel Pamoate»
(Created page with "==Administration== *Type: Antiparasitic *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *11mg/kg once ==Pediatric Dosing== * > 2yo: 11...") |
Sin resumen de edición |
||
| Línea 36: | Línea 36: | ||
==Comments== | ==Comments== | ||
*Indicated to treat infection with [[enterobius]], [[ | *Indicated to treat infection with [[enterobius]], [[ascaris]], and other similar worms | ||
==See Also== | ==See Also== | ||
*[[Parasitic | *[[Parasitic diseases]] | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Revisión del 20:58 7 nov 2016
Administration
- Type: Antiparasitic
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- 11mg/kg once
Pediatric Dosing
- > 2yo: 11mg/kg once
Special Populations
- Pregnancy Rating: C
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
- Nausea/vomiting, diarrhea
- Headache, dizziness, somnolence
Pharmacology
- Half-life:
- Metabolism:
- Excretion: Fecal
Mechanism of Action
- depolarizing neuromuscular blocking agent, causes spastic paralysis in the worms
Comments
- Indicated to treat infection with enterobius, ascaris, and other similar worms